The Patent Finder

Sphinx Pharmaceuticals Corporation

Also on record
Records under this name other than patents Sphinx Pharmaceuticals Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Sphinx Pharmaceuticals Corporation

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 5,141,9571,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase C
Term ended
Term ended no later than Aug 25, 2012 · Low confidence
Term endedTerm ended no later than Aug 25, 2012Low confidence
US 5,204,370Bis-(hydroxyalkylamino)-anthraquinone inhibitors of protein kinase C
Term ended
Term ended no later than Apr 20, 2013 · Low confidence
Term endedTerm ended no later than Apr 20, 2013Low confidence
US 5,216,014Furo-coumarinsulfonamides as protein kinase C inhibitors
Term ended
Term ended no later than Jun 1, 2013 · Low confidence
Term endedTerm ended no later than Jun 1, 2013Low confidence
US 5,270,310N-aminoalkyl amide inhibitors of protein kinase C
Formerly held
Term ended
Term ended no later than Dec 14, 2013 · Low confidence
Term endedTerm ended no later than Dec 14, 2013Low confidence
US 5,292,737N,N'-bis(sulfonamido)-2-amino-4-iminonaphthalen-1-ones and N,N'-bis(amido)-2-amino-4-iminonaphthalen-1-ones
Term ended
Term ended no later than Mar 8, 2014 · Low confidence
Term endedTerm ended no later than Mar 8, 2014Low confidence
US 5,344,841Bis-(hydroxylakylamino)-anthraquinone inhibitors of protein kinase C
Term ended
Term ended no later than Sep 6, 2014 · Low confidence
Term endedTerm ended no later than Sep 6, 2014Low confidence
US 5,360,8181,3-dioxane derivatives having protein kinase C inhibitory activity
Term ended
Term ended no later than Nov 1, 2014 · Low confidence
Term endedTerm ended no later than Nov 1, 2014Low confidence
US 5,369,030Method of inducing cellular differentiations and altering cell phenotype using ceramide analogs
Term ended
Term ended no later than Nov 29, 2014 · Low confidence
Term endedTerm ended no later than Nov 29, 2014Low confidence
US 5,432,198Vicinal-substituted carbocyclic compounds as therapeutic agents
Term ended
Term ended no later than Jul 11, 2015 · Low confidence
Term endedTerm ended no later than Jul 11, 2015Low confidence
US 5,436,243Aminoanthraquinone derivatives to combat multidrug resistance
Formerly held
Term ended
Term ended no later than Jul 25, 2015 · Low confidence
Term endedTerm ended no later than Jul 25, 2015Low confidence
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited